P010. OnabotulinumtoxinA for treatment of chronic migraine: results after 1 year of treatment

The Journal of Headache and Pain

Poster Presentation

Francesco De Cesaris¹  Eleonora Rossi¹  Chiara Lupi¹  Silvia Benemei¹  Pierangelo Geppetti¹ 

[1] SOD Centro Cefalee e Farmacologia Clinica AOU Careggi, Dipartimento di Scienze della Salute, Università degli Studi di Firenze, Florence, Italy;

关键词: Migraine;    Amitriptyline;    Topiramate;    Chronic Migraine;    Calcium Channel Antagonist;   

DOI  :  10.1186/1129-2377-16-S1-A110

来源: Springer

【 授权许可】

CC BY   
© Rossi et al. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.